Eversheds has advised H2 Equity Partners (‘H2’) on its investment into NRS Healthcare (‘NRS’). H2 partially bought out existing shareholder LDC and has become the majority shareholder in NRS, with LDC and the management team retaining a minority interest.

NRS is a market leading provider of specialist community healthcare equipment and services the NHS and local authorities. Based in Leicestershire, NRS employs 734 employees across the UK and is forecast to generate sales of £132 million in its current financial year.

The Eversheds was led by Private Equity Partner James Trevis, assisted by Corporate Partner Alasdair Outhwaite, Principal Associate Louise Finnie, Associate Elizabeth Tindall, Associate Alex McCarney and Banking Senior Associate Ben Edwards.

James Trevis commented:

“Following the success of the acquisition by H2 of Eurocell on which Eversheds advised, we were delighted to work with H2 again on this strategically important acquisition. We look forward to continuing our relationship with H2 as they develop their presence in the UK market”.

Commenting on the acquisition, Simon Gilbert, Partner at H2 said:

“This is an attractive sector that has been growing strongly due to outsourcing of care services and the demands of an ageing population. The acquisition was completed on a tight timetable and Eversheds did an excellent job of marshalling us through it.”